Capacity Building and Strengthening of Hospital Infection Control to detect, prevent and respond to antimicrobial resistance in India

Archived

Centers for Disease Control - CGH

Description

Antimicrobial resistance (AMR) is a global patient safety and public health concern. Hospital acquired infections (HAI) lead to adverse outcomes and increased cost of treatment. Effective infection prevention and control (IPC) interventions can reduce HAIs. The Government of India has prioritized combating AMR. The All India Institute of Medical Science (AIIMS) at the direction of the Indian Council of Medical Research (ICMR) is directing the only standardized HAI surveillance network in India with 32 nodal centers in 22 states. Through this NOFO, AIIMS will work with CDC and ICMR to implement a step-wise, scalable approach to generate and report accurate HAI and AMR data. In the first year, sites will perform HAI surveillance, improve antimicrobial use and use data to target IPC activities. Short-term outcomes include develop a trained workforce; ensure standardization of surveillance; and strengthen IPC programs. The long-term objective is a sustainable AMR and HAI surveillance network that produces quality data to inform the development and implementation of evidence-based national policies on IPC, antimicrobial stewardship and HAI prevention. The Government of India has prioritized combating AMR. The All India Institute of Medical Science (AIIMS) at the direction of the Indian Council of Medical Research (ICMR) is directing the only standardized HAI surveillance network in India with 32 nodal centers in 22 states. Through this NOFO, AIIMS will work with CDC and ICMR to implement a step-wise, scalable approach to generate and report accurate HAI and AMR data. In the first year, sites will perform HAI surveillance, improve antimicrobial use and use data to target IPC activities. Short-term outcomes include develop a trained workforce; ensure standardization of surveillance; and strengthen IPC programs. The long-term objective is a sustainable AMR and HAI surveillance network that produces quality data to inform the development and implementation of evidence-based national policies on IPC, antimicrobial stewardship and HAI prevention.

Who can apply

  • Others

Contact

Laura Shelby<br/>lks2@cdc.gov
lks2@cdc.gov

Key dates & funding
  • PostedMay 18, 2021
  • ClosesJul 20, 2021
  • Award floor$0
  • Award ceiling$0
  • Program funding$205,000,000
  • Expected awards1
  • CFDA93.318
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro